N@N

HAWTHORNE, Calif.--([ BUSINESS WIRE ])--[ OSI Systems, Inc. ] (NASDAQ: OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received clearance under Section 510(k) from the U.S. Food and Drug Administration to market the Arkon^TM high-performance anesthesia delivery system. Building upon Spacelabsa sixty years of experience in designing anesthesia systems and incorporating the latest technology, Arkona" provides the anesthesiologist with highly accurate and reliable tools to monitor a patient under anesthesia more effectively. Using innovative concepts in industrial design, Arkonas flexible workstation configuration also creates an environment for the anesthesiologist to manage overall workflow in the operating room more efficiently.

"Arkona" is a culmination of several years of product development where the Spacelabs team embarked on a mission to develop an anesthesia workstation enabling anesthesiologists to achieve the perfect balance between practice and patient, by providing leading technology with a user interface that is intuitive and highly customizable."

aArkona" is a culmination of several years of product development where the Spacelabs team embarked on a mission to develop an anesthesia workstation enabling anesthesiologists to achieve the perfect balance between practice and patient, by providing leading technology with a user interface that is intuitive and highly customizable.a said Deepak Chopra, OSI Systems CEO.

About OSI Systems, Inc.

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic system and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems Inc. or any of its subsidiary companies, visit [ www.osi-systems.com ]. News Filter: OSIS-G

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company's expectations, goals or intentions about the future, including, the Company's contracts to deliver a broad range of solutions to customers in the healthcare industry.The actual results may differ materially from those described in or implied by any forward-looking statement.